Fidelity Select Health Care Portfolio (FSPHX)

Fund Assets	6.30B
Expense Ratio	0.62%
Min. Investment	$0.00
Turnover	69.00%
Dividend (ttm)	5.15
Dividend Yield	18.00%
Dividend Growth	98.11%
Payout Frequency	Semi-Annual
Ex-Dividend Date	Apr 10, 2026

Previous Close	28.59
YTD Return	14.38%
1-Year Return	23.18%
5-Year Return	12.37%
52-Week Low	23.45
52-Week High	31.44
Beta (5Y)	0.63
Holdings	156
Inception Date	Jul 14, 1981

About FSPHX

The Fidelity Select Health Care Portfolio is a sector-specific mutual fund that offers focused exposure to the health care industry. It primarily invests in companies engaged in the design, manufacture, or sale of health care products and services, covering a wide spectrum from pharmaceutical giants to medical device innovators and biotechnology firms. With a core strategy of fundamental analysis, the fund targets companies poised for long-term growth within the health sector, leveraging the expertise of seasoned portfolio managers and a robust research team. The portfolio is structured to be non-diversified, concentrating a significant portion of assets in the top industry leaders, allowing investors to capitalize on high-conviction health care plays. The health care sector is recognized for its relative resilience and innovation-driven growth, making the Fidelity Select Health Care Portfolio a strategic vehicle for those seeking targeted participation in this pivotal segment of the economy. As part of Fidelity’s broader health care investment lineup, this fund supports investors aiming to allocate capital toward advancements in medicine, diagnostics, and therapeutic solutions, reflecting trends that shape global public health and wellness.

• Fund Family: Fidelity
• Category: Health
• Performance Rating: Above Average
• Risk Rating: Average
• Stock Exchange: NASDAQ
• Ticker Symbol: FSPHX
• Index: S&P 500 TR

Performance

FSPHX had a total return of 23.18% in the past year, including dividends. Since the fund's inception, the average annual return has been 14.26%.

Top 10 Holdings

38.61% of assets

Name	Symbol	Weight
Eli Lilly and Company	LLY	7.91%
Danaher Corporation	DHR	6.52%
Thermo Fisher Scientific Inc.	TMO	5.04%
Johnson & Johnson	JNJ	4.59%
UnitedHealth Group Incorporated	UNH	3.92%
AbbVie Inc.	ABBV	2.73%
Ascendis Pharma A/S	ASND	2.26%
Alnylam Pharmaceuticals, Inc.	ALNY	1.99%
Merck & Co., Inc.	MRK	1.88%
Gilead Sciences, Inc.	GILD	1.79%

Dividend History

Ex-Dividend	Amount	Pay Date
Apr 10, 2026	$3.075	Apr 13, 2026
Dec 26, 2025	$2.070	Dec 29, 2025
Apr 11, 2025	$0.591	Apr 14, 2025
Dec 26, 2024	$2.006	Dec 27, 2024
Apr 12, 2024	$0.930	Apr 15, 2024
Apr 8, 2022	$0.589	Apr 11, 2022

Data Sources: Tiingo, Financial Modeling Prep, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Financial Modeling Prep. Several fund data points are also provided by Finnhub.

Last checked:

Aug 18, 2026

Data Sources Report a data error